At the 32nd week of gestation, her oral glucose tolerance test (OGTT ... with typical cutaneous lesions resembling those seen in subacute cutaneous lupus erythematosus (SCLE) (3). A retrospective ...

After a previously reported positive phase 2 trial in systemic lupus erythematosus (SLE), the TYK2 inhibitor deucravacitinib ...

Pericarditis recurrence in lupus is more likely — and has a dose-dependent relationship — with oral prednisone treatment, ...

Anifrolumab can substantially lower the risk for long-term organ damage progression in patients with moderate to severe ...

New research suggests the use of oral prednisone should be limited in patients with systemic lupus erythematosus with a history of recurrent pericarditis.

Merck tested its oral TLR7/8 inhibitor enpatoran in two forms of lupus. The company reported positive phase 2 data from the cohort of cutaneous lupus erythematosus (CLE) patients late last year.

A new study sought to identify the frequency and determinants of flares for with people with systemic lupus erythematosus (SLE) with persistently active disease (PAD). Researchers found that both ...

The latest study builds on earlier research about systemic lupus erythematosus, including findings that the first symptoms of more than half of lupus patients were initially misdiagnosed as ...